13 Einträge gefunden

1. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

   1. Chun, Felix
   2. Suardi, Nazareno
   3. Capitanio, Umberto
   4. Jeldres, Claudio
   5. Ahyai, Sascha
   6. Graefen, Markus
   7. Haese, Alexander

   2008 - Forschungsinformationssystem des UKE
2. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

   1. Capitanio, Umberto
   2. Ahyai, Sascha
   3. Graefen, Markus
   4. Jeldres, Claudio
   5. Shariat, Shahrokh F
   6. Erbersdobler, Andreas
   7. Schlomm, Thorsten

   2008 - Forschungsinformationssystem des UKE
3. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

   1. Chun, Felix
   2. Briganti, Alberto
   3. Jeldres, Claudio
   4. Erbersdobler, Andreas
   5. Schlomm, Thorsten
   6. Steuber, Thomas
   7. Gallina, Andrea

   2007 - Forschungsinformationssystem des UKE
4. Development and external validation of an extended 10-core biopsy nomogram.

   1. Chun, Felix
   2. Briganti, Alberto
   3. Graefen, Markus
   4. Montorsi, Francesco
   5. Porter, Christopher
   6. Scattoni, Vincenzo
   7. Gallina, Andrea

   2007 - Forschungsinformationssystem des UKE
5. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

   1. Steuber, Thomas
   2. Graefen, Markus
   3. Haese, Alexander
   4. Erbersdobler, Andreas
   5. Chun, Felix K-H
   6. Schlom, Thorsten
   7. Perrotte, Paul

   2006 - Forschungsinformationssystem des UKE
6. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.

   1. Chun, Felix K-H
   2. Briganti, Alberto
   3. Shariat, Shahrokh F
   4. Graefen, Markus
   5. Montorsi, Francesco
   6. Erbersdobler, Andreas
   7. Steuber, Thomas

   2006 - Forschungsinformationssystem des UKE
7. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

   1. Steuber, Thomas
   2. Erbersdobler, Andreas
   3. Graefen, Markus
   4. Haese, Alexander
   5. Huland, Hartwig
   6. Karakiewicz, Pierre I

   2006 - Forschungsinformationssystem des UKE
8. Development and internal validation of preoperative transition zone prostate cancer nomogram.

   1. Steuber, Thomas
   2. Chun, Felix K-H
   3. Erbersdobler, Andreas
   4. Briganti, Alberto
   5. Haese, Alexander
   6. Graefen, Markus
   7. Schlomm, Thorsten

   2006 - Forschungsinformationssystem des UKE
9. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

   1. Chun, Felix K-H
   2. Steuber, Thomas
   3. Erbersdobler, Andreas
   4. Currlin, Eike
   5. Walz, Jochen
   6. Schlomm, Thorsten
   7. Haese, Alexander

   2006 - Forschungsinformationssystem des UKE
10. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

    1. Walz, Jochen
    2. Graefen, Markus
    3. Chun, Felix K-H
    4. Erbersdobler, Andreas
    5. Haese, Alexander
    6. Steuber, Thomas
    7. Schlomm, Thorsten

    2006 - Forschungsinformationssystem des UKE
11. Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.

    1. Eichelberg, Christian
    2. Erbersdobler, Andreas
    3. Haese, Alexander
    4. Schlomm, Thorsten
    5. Chun, Felix K H
    6. Currlin, Eike
    7. Walz, Jochen

    2006 - Forschungsinformationssystem des UKE
12. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.

    1. Steuber, Thomas
    2. Niemela, Pauliina
    3. Haese, Alexander
    4. Pettersson, Kim
    5. Erbersdobler, Andreas
    6. Felix Chun, K-H
    7. Graefen, Markus

    2005 - Forschungsinformationssystem des UKE
13. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

    1. Haese, Alexander
    2. Graefen, Markus
    3. Steuber, Thomas
    4. Becker, Charlotte
    5. Noldus, Joachim
    6. Erbersdobler, Andreas
    7. Huland, Edith

    2003 - Forschungsinformationssystem des UKE